RT Journal Article T1 Treatment of COPD Exacerbation in Switzerland: Results and Recommendations of the European COPD Audit. A1 Buess, Michael A1 Schilter, Daniel A1 Schneider, Tino A1 Maurer, Marc A1 Borer, Heinz A1 Thurnheer, Robert A1 Köhler, Erich A1 Junker, Lilian A1 Jahn, Kathleen A1 Grob, Michael A1 Rüdiger, Jochen A1 Geiser, Thomas A1 Helfenstein, Erich A1 Solèr, Markus A1 Fiechter, René A1 Sigrist, Thomas A1 Brun, Patrick A1 Barandun, Jürg A1 Koltai, Eva A1 López-Campos, José Luis A1 Hartl, Sylvia A1 Roberts, Michael A1 Schumann, Desiree M A1 Tamm, Michael A1 Stolz, Daiana K1 Audit K1 Bundle K1 Chronic obstructive pulmonary disease K1 ERS K1 Europe K1 Exacerbation K1 GOLD K1 Recommendations K1 Switzerland K1 Therapy AB The European COPD Audit initiated by the European Respiratory Society (ERS) evaluated the management of hospital admissions due to exacerbation of chronic obstructive pulmonary disease (COPD) in several European countries. Data on the treatment of severe acute exacerbations of COPD (AECOPDs) in Switzerland are scarce. In light of the GOLD 2010 guidelines, this work aims to examine the quality of care for AECOPD and to provide specific recommendations for the management of severe AECOPD in Switzerland. A total of 295 patients requiring hospital admission to 19 Swiss hospitals due to exacerbation of COPD during a predefined 60 days in 2011 were included in the study. We compared the Swiss data to the official GOLD 2010 recommendations and to the results of the other European countries. Approximately 43% of the Swiss patients with severe AECOPD were current smokers at hospital admission, compared to 33% of the patients in other European countries (p Considering the overall high standard of health care in Switzerland, in light of the GOLD 2010 guidelines we are able to make 7 recommendations to improve and standardize the management of severe AECOPD for patients treated in Switzerland. YR 2017 FD 2017-07-19 LK http://hdl.handle.net/10668/11421 UL http://hdl.handle.net/10668/11421 LA en DS RISalud RD Apr 9, 2025